metabolic
Orforglipron
Oral small-molecule GLP-1 agonist
Cheapest offer
$16.50/mg
2 vendors tracked2 live pricesLast crawl: 2026-09-09 00:02 UTC
About
An oral non-peptide GLP-1 receptor agonist in Phase 3 for obesity and type-2 diabetes. Typically sold as capsules in research-compound form.
Also known as: LY-3502970
Reconstitution calculator
!
For research purposes only. Not for human consumption. Always verify calculations independently.
Cost-per-dose recalculates as you adjust the calculator above.
Orforglipron · 6mg
2 vendors
B-
Operational$99.00
$16.50/mg· $4.13/dose
In stock◎ Best $/mg
Watch
$99.00
$16.50/mg· $4.13/dose
In stock▲ 0.0% vs best
| Vendor | Grade | Risk | Price | $/mg | Trend | $/dose at 0.25 mg | Stock | |
|---|---|---|---|---|---|---|---|---|
| Atomik Labz US | B- | Operational | $99.00 ◎ Best $/mg | $16.50 | $4.13 | In stock | Buy with code → | |
| Solution Peptides US | B- | Watch | $99.00 ▲ 0.0% | $16.50 | $4.13 | In stock | Visit → |
Sort:
Last crawl 2026-09-09Sort:
2026-09-09Research use only. The compounds listed on this page are not approved for human use through research-chemical channels. Nothing on this page is medical advice. Consult a qualified clinician before considering any peptide protocol. See affiliate disclosure and our scoring methodology.
Keep exploring
More on Orforglipron & related research
Related peptides
- Semaglutide— GLP-1 agonist for metabolic research
- Tirzepatide— Dual GLP-1/GIP agonist
- Retatrutide— Triple GCG/GIP/GLP-1 agonist
- Mazdutide— GLP-1/glucagon dual agonist
- Survodutide— Glucagon/GLP-1 dual agonist
Compare head-to-head
Vendors selling this peptide